Used primarily as an intermediate in the synthesis of biologically active compounds, particularly in the development of sulfonamide-based pharmaceuticals. Its structure supports the creation of hydrazine derivatives with potential antimicrobial and anticonvulsant properties. The trifluoroacetyl group enhances metabolic stability and lipophilicity, making it valuable in medicinal chemistry for optimizing drug candidates. It is also employed in research settings to design enzyme inhibitors and explore structure-activity relationships in heterocyclic compound libraries.